AMER DIABETES ASSOC 1701 N BEAUREGARD ST, ALEXANDRIA, VA 22311-1717 USA, pp A164A164 Swinnen SG, Dain M-P, Aronson R et al (2010) A 24-week, randomized, treat-to-target trial comparing initiation of insulin glargine once-daily with insulin detemir twice-daily in patients with type 2 diabetes inadequately controlled on oral glucose-lowering drugs
B12 also contributes to muscle and gut health
They are susceptible to degradation pathways that small molecules simply do not face, including deamidation, oxidation, aggregation, and hydrolysis
REFERENCES: (1) Advancing regenerative surgery in orthopaedic sports medicine: the critical role of the surgeon (2) The Clinical Use of Human Culture-Expanded Autologous Bone Marrow Mesenchymal Stem Cells Transplanted on Platelet-Rich Fibrin Glue in the Treatment of Articular Cartilage Defects (3) Platelet-Rich Fibrin and Its Emerging Therapeutic Benefits for Musculoskeletal Injury Treatment (4) Platelet-Rich Fibrin Scaffolds for Cartilage and Tendon Regenerative Medicine: From Bench to Bedside (5) From Platelet-Rich Plasma to Advanced Platelet-Rich Fibrin: Biological Achievements and Clinical Advances in Modern Surgery (6) Leucocyte and Plateletrich Fibrin: a carrier of autologous multipotent cells for regenerative medicine (7) Cytokine and Growth Factor Delivery from Implanted Platelet-Rich Fibrin Enhances Rabbit Achilles Tendon Healing (8) Cartilage Defect Treatments: A Systematic Review and Meta-Analyses (9) Regenerative approaches for the treatment of early OA (10) Stem Cells in Osteochondral Tissue Engineering (11) Circulating stem cells (12) Peripheral blood and bone marrow hematopoietic stem cells: are they the same
